Search

Background: Early risk stratification is necessary for optimal determination of the treatment strategy in cardiogenic shock (CS) complicating acute coronary syndrome (ACS). Therefore, we evaluated the prognostic impact of an intra-aortic balloon pump on the cardiogenic shock (IABP-SHOCK) II score according to the treatment strategies in ACS complicated by CS using the RESCUE (REtrospective and prospective observational Study to investigate Clinical oUtcomes and Efficacy of left ventricular assist device for Korean patients with cardiogenic shock) registry. Methods: The RESCUE registry contains multicenter observational retrospective and prospective cohorts that include 1247 patients with CS from 12 centers in Korea. A total of 865 patients with ACS complicated by CS were selected and stratified into low-, intermediate- and high-risk categories according to their IABP-SHOCK II scores and then according to treatment: non-mechanical support, IABP, and extracorporeal membrane oxygenators (ECMOs). The primary outcome was all-cause mortality during follow-up. Results: The observed mortality rates for the low-, intermediate-, and high-IABP-SHOCK II score risk categories were 28.8%, 52.4%, and 69.8%, respectively (p < 0.01). Patients in the non-mechanical support and IABP groups showed an increasingly elevated risk of all-cause mortality as their risk scores increased from low to high. In the ECMO group, the risk of all-cause mortality did not differ between the intermediate- and high-risk categories (HR = 1.21, 95% CI: 0.81–1.81, p = 0.33). The IABP-SHOCK II scores for the non-mechanical support and IABP groups showed a better predictive performance (area under curve [AUC] = 0.70, 95% CI: 0.65–0.76) for mortality compared with the EMCO group (AUC = 0.61, 95% CI 0.54–0.67; p-value for comparison = 0.02). Conclusions: Risk stratification using the IABP-SHOCK II score is useful for predicting mortality in ACS complicated by CS when patients are treated with non-mechanical support or IABP. However, its prognostic value may be unsatisfactory in severe cases where patients require ECMOs. [ABSTRACT FROM AUTHOR]

Introduction: Pump-controlled retrograde trial off has recently been introduced as an effective method for weaning from veno-arterial extracorporeal membrane oxygenation in pediatric patients. However, studies on pump-controlled retrograde trial off in adults are still lacking. Thus, this study aimed to examine the outcomes of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation in adult patients. Methods: Between January 2018 and July 2019, 87 consecutive adult patients underwent veno-arterial extracorporeal membrane oxygenation support, of whom 47 (54.0%) underwent pump-controlled retrograde trial off for weaning from extracorporeal membrane oxygenation and were enrolled in this study. The pump-controlled retrograde trial off results, extracorporeal membrane oxygenation reapplication rate, and clinical outcomes were analyzed. Results: Of the 47 patients, 38 (80.9%) were weaned from veno-arterial extracorporeal membrane oxygenation on the first attempt of pump-controlled retrograde trial off, 5 (10.6%) on the second attempt, and 4 (8.5%) on the third attempt. Three patients were converted to venovenous extracorporeal membrane oxygenation by desaturation but had stable blood pressure during pump-controlled retrograde trial off. No extracorporeal membrane oxygenation reapplication was performed within 3 days after removal, and two patients underwent veno-arterial extracorporeal membrane oxygenation during follow-up. No complications associated with pump-controlled retrograde trial off occurred during the weaning process, including thromboembolic events. Five in-hospital deaths (10.6%) occurred after weaning from extracorporeal membrane oxygenation. Conclusion: Pump-controlled retrograde trial off is an effective method to safely wean from veno-arterial extracorporeal membrane oxygenation in adult patients. It is simple and can be easily implemented without additional invasive procedures and may help prevent deterioration of the cardiovascular system after weaning from veno-arterial extracorporeal membrane oxygenation. [ABSTRACT FROM AUTHOR]

Objectives: To identify whether the prognostic implications of Vasoactive Inotropic Score according to use of mechanical circulatory support differ in the treatment of acute myocardial infarction complicated by cardiogenic shock.Design: A multicenter retrospective and prospective observational cohort study.Setting/patient: The REtrospective and prospective observational Study to investigate Clinical oUtcomes and Efficacy registry includes 1,247 patients with cardiogenic shock from 12 centers in Korea. A total of 836 patients with acute myocardial infarction complicated by cardiogenic shock were finally selected, and the study population was stratified by quartiles of Vasoactive Inotropic Score (< 10, 10-30, 30-90, and > 90) for the present study.Interventions: None.Measurements and Main Results: Primary endpoint was in-hospital mortality and secondary endpoint was follow-up mortality. Among the study population, 326 patients (39.0%) received medical treatment alone, 218 (26.1%) received intra-aortic balloon pump, and 292 (34.9%) received extracorporeal membrane oxygenation. In-hospital mortality occurred in 305 patients (36.5%) and was significantly higher in patients with higher Vasoactive Inotropic Score (15.6%, 20.8%, 40.2%, and 67.3%, for < 10, 10-30, 30-90, and > 90; p < 0.001). Vasoactive Inotropic Score showed better ability to predict in-hospital mortality in acute myocardial infarction patients with cardiogenic shock who received medical treatment alone (area under the curve: 0.797; 95% CI, 0.728-0.865) than in those who received intra-aortic balloon pump (area under the curve, 0.704; 95% CI, 0.625-0.783) or extracorporeal membrane oxygenation (area under the curve, 0.644; 95% CI, 0.580-0.709). The best cutoff value of Vasoactive Inotropic Score for the prediction of in-hospital mortality also differed according to the use of mechanical circulatory support (16.5, 40.1, and 84.0 for medical treatment alone, intra-aortic balloon pump, and extracorporeal membrane oxygenation, respectively). There was a significant interaction between Vasoactive Inotropic Score as a continuous value and the use of mechanical circulatory support including intra-aortic balloon pump (interaction-p = 0.006) and extracorporeal membrane oxygenation (interaction-p < 0.001) for all-cause mortality during follow-up.Conclusions: High Vasoactive Inotropic Score was associated with significantly higher in-hospital and follow-up mortality in patients with acute myocardial infarction complicated by cardiogenic shock. The predictive value of Vasoactive Inotropic Score for mortality was significantly higher in acute myocardial infarction patients with cardiogenic shock treated by medical treatment alone than in those treated by mechanical circulatory support such as intra-aortic balloon pump or extracorporeal membrane oxygenation. [ABSTRACT FROM AUTHOR]

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been widely applied in various cardiogenic shock (CS). However, there is a lack of consensus on the timing of weaning. Proposed algorithm is, if the patient is tolerable to minimum flow of 1-1.5/min, some echocardiographic and hemodynamic parameters are reasonable, de-cannulation could be considered. The aim of this study was to investigate the outcome of back flow shunt test our team has been done for years, which gives the transient loading condition to right ventricle before final decision of de-cannulation of VA ECMO. We retrospectively reviewed all adult VA-ECMO patients treated at a single tertiary hospital in South Korea between January 2018 to July 2019. Demographic data, diagnosis, echocardiography findings, ECMO configuration, mortality and morbidity data were collected. Backflow shunt test was done by simply reverse the Rota flow with dial to achieve negative flow from artery to vein. The test was stopped by simply dialing back to previous ECMO flow in case of unstable vital signs (Figure) Total of 47 patients underwent back-flow shunt test; 38 were de-cannulated on the 1st trial, 5 were on 2nd, 4 were on 3rd. The mean age was 58±16, 29 (63%) were male and 18 (37%) were female. The etiology of CS was ischemia 32 (70%), myocarditis 6 (13%), non-ischemic heart failure 5 (11%), refractory arrhythmia 2 (4%). All patients were successfully de-cannulated without hemodynamic deterioration. There was no thromboembolic event or oxygenator membrane thrombosis during shunt test. None of the patients needed re-insertion of VA ECMO within 3 days after weaning. In-hospital death after weaning were 4 (8.5%). Our study suggests that back-flow shunt test is a simple, and reversible weaning method applied in CS from various etiology without stopping the VA ECMO and concern of thromboembolism. This test could be effectively applied to the patients with marginal heart function. [ABSTRACT FROM AUTHOR]

Introduction: Mortality is very high in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) or cardiac arrest despite intensive use of percutaneous coronary intervention (PCI). Although current guidelines still recommend rapid revascularization in these high-risk patients, several studies showed the benefit of extracorporeal membrane oxygenation (ECMO)-assisted PCI. Hypothesis: ECMO support before revascularization might be beneficial in patients with AMI complicated by profound CS after resuscitated cardiac arrest. Methods: Among 116,374 patients experiencing out-of-hospital cardiac arrest in all emergency medical service of South Korea between 2013 and 2016, a total of 147 resuscitated patients with AMI complicated by profound CS who were treated with both PCI and ECMO were enrolled. Exclusion criteria were as follows: non-cardiac arrest, duration of cardiopulmonary resuscitation < 20 minutes, patients without restoration of spontaneous circulation, patients treated with thrombolysis, patients who did not receive PCI, patients did not receive ECMO treatment, and cases of failed PCI. Enrolled patients were divided into two groups according to timing of ECMO; pre-PCI ECMO group (n = 82) vs. post-PCI ECMO group (n = 65). We compared 30-day mortality between two groups. Results: Age and proportion of male gender were similar between 2 groups. The rate of bystander CPR (29.3% vs. 29.2%, p = 0.996) and shockable rhythm at emergency room (26.8% vs. 26.2%, p = 0.927) were also comparable in 2 groups. Although total duration of CPR was similar between 2 groups (57.4±27.6 vs. 52.0±28.8 minutes, p = 0.313), door to revascularization time was significantly longer in pre-PCI ECMO group than post-PCI ECMO group (123.7±57.6 vs. 105.5±39.1 minutes, p = 0.030). At 30-days, overall mortality was 80.3% (118 patients) in study population, and it was significantly lowered in pre-PCI ECMO group (72.0% vs. 90.8%, p = 0.004). In multivariate Cox-regression analysis, pre-PCI ECMO reduced 30-day mortality compared to post-PCI ECMO (hazard ratio [HR] 0.68, 95% confidence interval [CI] 0.47-0.98, p = 0.041). Bystander CPR , shockable rhythm at emergency room and successful therapeutic hypothermia were also associated with reduced 30-day mortality. Conclusions: ECMO treatment before PCI was associated with reduced 30-day mortality compared to ECMO after revascularization in patients with AMI complicated by profound CS after resuscitated cardiac arrest. [ABSTRACT FROM AUTHOR]